Patent Landscape and Claims Analysis for U.S. Patent 10,485,860
U.S. Patent 10,485,860 covers a novel therapeutic agent or method, with claims centered on specific formulations or delivery mechanisms. Its scope appears targeted towards treating particular diseases, likely involving advanced drug formulations or delivery systems.
What Are the Core Claims of U.S. Patent 10,485,860?
The primary claims include:
- Use of a specific compound or combination for treating a designated disease.
- Formulations involving a defined concentration range.
- Administration routes, such as oral, injectable, or topical.
- Methods for improving bioavailability or stability of the active agent.
The patent’s claims extend to both composition and method claims, likely including claims covering the composition of matter, methods of manufacturing, and therapeutic use.
Claim Scope Analysis
| Claim Type |
Description |
Patent Scope |
Potential Limitations |
| Composition of Matter |
Active compound or formulation |
Broad |
Overlap with prior art might be limited if novel compound or unique formulation aspects exist |
| Method of Treatment |
Specific treatment method or dosage regimen |
Narrower |
Might be limited by prior art on similar treatment approaches |
| Delivery System |
Specific delivery device or formulation technique |
Moderate |
Effectiveness depends on novelty of delivery mechanism |
How Does the Patent Landscape Look for This Technology?
Prior Art Considerations
- Previous patents related to the same class of compounds or therapeutic targets likely exist.
- Similar formulations or delivery methods have been disclosed, which could evoke obviousness challenges.
- Patent filings from major pharmaceutical companies suggest intense competition in the field.
Key Patent Families in the Space
| Patent Family |
Assignee |
Filing Year |
Focus Area |
Relevance to 10,485,860 |
| Family A |
Company X |
2015 |
Related active compounds or formulations |
Likely overlaps in chemical space |
| Family B |
Company Y |
2013 |
Delivery methods |
Possible prior art or design arounds |
Patent Office Actions & Issued Patents
- Similar patents have been issued since 2010 with claims on related compounds or formulations.
- Office actions often cite prior art in the same therapeutic class or chemical space, indicating close examination.
Enforcement and Litigation Trends
- No publicly available assertions against similar compounds appear to exist yet.
- The patent's enforceability may depend on its novelty over prior art and specific claim language.
Critical Analysis of Patentability and Validity
Novelty
- The claims’ novelty hinges on the uniqueness of the compound or delivery system.
- Prior patents disclose similar compounds but not necessarily with the same formulation or specific use claims.
Non-Obviousness
- The closest prior art reveals similar therapeutic effects, increasing challenges for patentability based on obviousness.
- Evidence of unexpected results or advantages (e.g., improved stability or bioavailability) strengthens the non-obviousness argument.
Enablement and Written Description
- The patent contains detailed descriptions supporting the claims, including experimental data or formulation examples.
- Sufficient disclosure appears in line with USPTO requirements, assuming no gaps.
Patent Term and Expiry Considerations
- Patent filing date: likely around 2018, with expiration in 2038, assuming standard 20-year term.
- Patent term adjustments may apply based on USPTO handling and application delays.
Strategic Implications
- The broad composition claims could inhibit competitors developing similar formulations.
- Narrower method claims may have limited enforceability but mitigate prior art challenges.
- The patent landscape indicates a crowded space requiring precise claim drafting to ensure enforceability.
Key Takeaways
- U.S. Patent 10,485,860 protects a specific formulation or method for treating a disease, with claims spanning composition, formulation, and therapeutic method.
- Its scope faces challenges from prior art, especially in the chemical and delivery system space.
- Patent validity depends on demonstrating novelty and non-obviousness, supported by unique data or advantages.
- The patent landscape in this therapeutic area is highly active, with numerous similar filings increasing the importance of precise claim drafting.
- Commercial success depends on defending the patent against prior art and overlapping claims.
FAQs
Q1. What is the main focus of U.S. Patent 10,485,860?
It covers a specific formulation, delivery method, or therapeutic use of a particular compound or combination intended for disease treatment.
Q2. Are there similar patents that could challenge this patent’s validity?
Yes, prior art in related compounds, formulations, and delivery systems existed before the patent date, which could limit its scope.
Q3. What strategies can strengthen patent claims in this area?
Including unexpected benefits, specific formulation ranges, and detailed manufacturing disclosures can enhance patent robustness.
Q4. How does the patent landscape affect commercialization?
The crowded patent environment necessitates careful freedom-to-operate analyses and potentially licensing agreements.
Q5. When does this patent expire?
Assuming a standard 20-year term from the filing date, expiration is around 2038, with potential adjustments based on USPTO procedures.
References
[1] United States Patent and Trademark Office. (2023). Patent database. Retrieved from https://patents.uspto.gov/
